Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsiamet Res Regulatory News (ARS)

Share Price Information for Asiamet Res (ARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.30
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.10 (7.692%)
Open: 1.35
High: 1.35
Low: 1.35
Prev. Close: 1.35
ARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2017 Annual Report & Financial Statements

27 Apr 2018 09:00

RNS Number : 3662M
Asiamet Resources Limited
27 April 2018
 

 

 

For Immediate Release London AIM

 

27 April 2018 Symbol: ARS

 

 

2017 Annual Report & Financial Statements

 

 

Asiamet Resources Limited ("Asiamet" or the "Company") is pleased to present its audited financial statements for the 12 months ended 31 December 2017 ("Financial Statements") as extracted from the Company's 2017 Annual Report which is now available on the Company website at www.asiametresources.com and will be provided to shareholders who have requested a printed or electronic copy. The Financial Statements should be read in conjunction with the 2017 Annual Report which contains the notes to the Financial Statements.

All dollars in the report are US$ unless otherwise stated.

 

Financial highlights include:

· 2017 net loss $7.5 million (2016: net loss 3.8 million)

· Closing cash as at 31 December $3.079 million (2016: $1.748 million)

· The Company has no debt.

 

 

 

 

 

ON BEHALF OF THE BOARD OF DIRECTORS

Peter Bird, Deputy Chairman and CEO

For further information, please contact: 

-Ends-

Peter BirdDeputy Chairman and CEO, Asiamet Resources LimitedTelephone: +61 3 8644 1300Email: peter.bird@asiametresources.com

 

Tony ManiniExecutive Chairman, Asiamet Resources LimitedTelephone: +61 3 8644 1300Email: tony.manini@asiametresources.com

 

FlowComms Limited

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: Sasha@flowcomms.com 

Asiamet Resources Nominated AdviserRFC Ambrian Limited

Andrew Thomson / Stephen Allen

Telephone: +61 8 9480 2500

Email: Andrew.Thomson@rfcambrian.com / Stephen.Allen@rfcambrian.com 

 

LiberumNeil Elliot, Clayton Bush, Kane Collings

Telephone: +44 7773 322679

Email: Neil.Elliot@Liberum.com

 

Optiva Securities LimitedChristian Dennis

Telephone: +44 20 3137 1903

Email: Christian.Dennis@optivasecurities.com

 

 

 

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

 

 

Consolidated Statement of Financial Position

As at 31 December 2017

 

 

 

 

2017

2016

 

 

 

 $'000

 $'000

 

ASSETS

 

 

 

Current assets

 

 

 

 

Cash

 

3,079

1,748

 

Receivables and other assets

 

586

254

 

Share subscription receivable

 

-

802

 

 

 

3,665

2,804

Non-current assets

 

 

 

 

Equipment

 

41

37

 

Security deposit

 

74

94

 

 

 

115

131

TOTAL ASSETS

 

3,780

2,935

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

1,054

1,017

 

Related party borrowings

 

-

233

 

 

 

1,054

1,250

Non-current liabilities

 

 

 

 

Provision for employee service entitlements

 

156

102

 

 

 

1,210

1,352

 

 

 

 

 

Equity

 

 

 

 

Share capital

 

8,528

7,060

 

Equity reserves

 

40,354

33,323

 

Other comprehensive loss

 

(12)

(2)

 

Accumulated Deficit

 

(46,293)

(38,791)

 

Parent entity interest

 

2,577

1,590

 

Non-controlling interest

 

(7)

(7)

 

 

 

2,570

1,583

TOTAL LIABILITIES AND EQUITY

 

3,780

2,935

 

 

 

Consolidated Statement of Comprehensive Loss

For the year ended 31 December 2017

 

 

 

 

2017

2016

 

 

 

$'000

$'000

 

Expenses

 

 

 

 

Accounting and audit

 

 (109)

 (100)

 

Consultants

 

 (668)

 (730)

 

Exploration and evaluation

 

 (4,628)

 (1,401)

 

Legal and Company Secretarial

 

 (139)

 (115)

 

General and administrative

 

 (249)

 (68)

 

Depreciation

 

 (24)

 (79)

 

Employee benefits

 

 (1,561)

 (1,121)

 

Share-based compensation

 

 (914)

 (300)

 

 

 

 (8,292)

 (3,914)

Other items

 

 

 

 

Taxation expense

 

-

 (7)

 

Foreign exchange gain

 

81

25

 

Gain on sale of subsidiary

 

708

100

 

Interest income

 

1

2

 

 

 

790

120

Net loss

 

 (7,502)

 (3,794)

Items that may not be reclassified subsequently to profit or loss:

 

 

 

 

Actuarial loss on employee service entitlements

 

 (10)

 (2)

Total comprehensive loss for the year

 

 (7,512)

 (3,796)

 

 

 

 

 

Net loss attributable to:

 

 

 

 

Equity holders of the parent

 

(7,244)

(3,794)

 

Non-controlling interests

 

(258)

-

 

 

 

 

Total comprehensive loss attributable to:

 

 

 

 

Equity holders of the parent

 

 (7,254)

 (3,794)

 

Non-controlling interests

 

(258)

-

 

 

 

 

 

Basic and diluted loss per common share

 

 (0.01)

 (0.01)

Weighted average number of shares outstanding (thousands)

 

772,537

609,750

 

 

 

Consolidated Statement of Cash Flows

For the year ended 31 December 2017

 

 

 

 

2017

2016

 

 

 

$'000

$'000

 

Cash provided from (used for):

 

 

 

 

 

 

 

 

Operating activities

 

 

 

Loss for the year

 

(7,512)

(3,794)

Adjustment for:

 

 

 

 

Depreciation

 

24

79

 

Share-based compensation

 

914

300

 

Unrealised foreign exchange gain

 

-

(4)

 

Gain on sale of subsidiary

 

(708)

-

Changes in non-cash working capital:

 

 

 

 

Receivables and other assets

 

(93)

24

 

Value Added Tax ("VAT")

 

(242)

(178)

 

Trade and other payables

 

61

667

 

Provision for employee service entitlements

 

59

59

 

 

 

(7,497)

(2,847)

Investing activities

 

 

 

 

Purchase of equipment

 

(26)

(24)

 

Proceeds on sale of subsidiary, net of cash sold

 

699

-

 

 

 

673

(24)

Financing activities

 

 

 

 

(Repayment of) Proceeds from related party loans

 

(233)

233

 

Proceeds from share subscription

 

802

-

 

Proceeds from equity raising

 

8,018

3,831

 

Equity raising costs

 

(432)

(224)

 

 

 

8,155

3,840

Increase in cash

 

1,331

969

 

 

 

 

 

Cash at beginning of the year

 

1,748

779

 

 

 

 

 

Cash at end of the year

 

3,079

1,748

 

Consolidated Statement of Changes in Equity

For the year ended 31 December 2017

 

 

 

 

 

 

Attributable to equity holders of the parent

 

 

 

 

Number of shares

 Share capital

Equity reserves

Other Comprehensive Loss

Accumulated Deficit

Total

Non-Controlling Interests

Total

 

 

'000

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

 

Balance at 1 January 2016

574,597

5,707

29,968

-

 (34,997)

678

 (7)

671

 

Equity raising

135,344

1,353

3,280

-

-

4,633

-

4,633

 

Warrant issues - brokers

-

-

165

-

-

165

-

165

 

Equity raising costs

-

-

 (390)

-

-

 (390)

-

 (390)

 

Share based compensation

-

-

300

-

-

300

-

300

 

Loss for the year

-

-

-

-

(3,794)

(3,794)

-

(3,794)

 

Actuarial loss on employee service entitlements

-

-

-

(2)

-

 (2)

-

 (2)

Balance at 31 December 2016

709,941

7,060

33,323

(2)

 (38,791)

1,590

 (7)

1,583

 

 

 

 

 

 

 

 

 

 

 

Equity raising

144,952

1,395

6,346

-

-

7,741

-

7,741

 

Warrant exercises - brokers

1,874

73

203

-

-

276

-

276

 

Equity raising costs

-

-

 (432)

-

-

 (432)

-

 (432)

 

Share based compensation

-

-

914

-

-

914

-

914

 

Cancelled shares

 (3)

-

-

-

-

-

-

-

 

Loss for the year

-

-

-

-

(7,244)

(7,244)

(258)

(7,502)

 

Actuarial loss on employee service entitlements

-

-

-

(10)

-

 (10)

-

 (10)

 

Contribution by parent in NCI

-

-

-

-

(258)

(258)

258

-

Balance at 31 December 2017

856,764

8,528

40,354

(12)

 (46,293)

2,577

 (7)

2,570

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR GRGDSIXDBGIR
Date   Source Headline
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Jan 20211:00 pmRNSDeal Update – Sale Process
4th Jan 20219:00 amRNSImportant Environmental Approval Received for BKM
30th Dec 20204:30 pmRNSNotice of General Meeting
24th Dec 20208:30 amRNSSale and Purchase Agreement Executed
11th Dec 202011:00 amRNSCorporate Update – KSK Sale Process
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
13th Oct 202010:09 amRNSMedia and Presentation Links
8th Oct 20204:41 pmRNSSecond Price Monitoring Extn
8th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20202:06 pmRNSSecond Price Monitoring Extn
8th Oct 20202:00 pmRNSPrice Monitoring Extension
8th Oct 202011:05 amRNSSecond Price Monitoring Extn
8th Oct 202011:00 amRNSPrice Monitoring Extension
8th Oct 20209:05 amRNSSecond Price Monitoring Extn
8th Oct 20209:00 amRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSHeads of Agreement Signed for KSK
7th Sep 20209:35 amRNSAppointment of Crowe U.K. LLP as Auditor
28th Aug 20208:05 amRNSAppointment of Chief Financial Officer
20th Aug 20207:02 amRNS2020 Interim Financial Statements
13th Aug 202010:30 amRNSIssue of Director Performance Rights
7th Aug 202011:49 amRNSLink to Investor Call and Q&A
17th Jul 20201:32 pmRNSAsiamet Responds to Media Article
3rd Jul 202012:05 pmRNSAGM 2020 Q&A Session
30th Jun 20205:25 pmRNSResult of AGM
26th Jun 202010:50 amRNSCorporate Update
22nd Jun 20203:55 pmRNSAnnual General Meeting Update
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
28th May 20204:00 pmRNSNotice of Annual General Meeting
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:45 amRNSCorporate Update
15th May 20209:05 amRNSSecond Price Monitoring Extn
15th May 20209:00 amRNSPrice Monitoring Extension
15th May 20207:00 amRNSAsiamet Receives Key Approval for BKM Project
5th May 20207:10 amRNS2019 Annual Report & Financial Statements
28th Apr 20209:01 amRNSKSK Receives Key Exploration Permit
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:00 pmRNSCorrection of Admission Date
25th Mar 202010:22 amRNSStrategic Investment and Development Partner
25th Mar 20209:05 amRNSSecond Price Monitoring Extn
25th Mar 20209:00 amRNSPrice Monitoring Extension
13th Mar 20209:46 amRNSAsiamet Business Update
10th Mar 20202:05 pmRNSSecond Price Monitoring Extn
10th Mar 20202:00 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSRelocates Head Office to Jakarta, Indonesia

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.